Skip to main content

Market Overview

Mid-Morning Market Update: Markets Open Higher; Pfizer Earnings Miss Views


Following the market opening Tuesday, the Dow traded up 0.5% to 28677.15 while the NASDAQ rose 0.86% to 9217.79. The S&P also rose, gaining 0.77% to 3,268.55.

Leading and Lagging Sectors

Information technology shares climbed 1% on Tuesday. Meanwhile, top gainers in the sector included Servicesource International Inc (NASDAQ: SREV), up 8%, and Sprout Social Inc (NASDAQ: SPT), up 5%.

In trading on Tuesday, industrial shares rose by just 0.2%.

Top Headline

Pfizer Inc. (NYSE: PFE) reported weaker-than-expected results for its fourth quarter.

Pfizer reported quarterly earnings of $0.55 per share, which missed the analyst consensus estimate of 57 cents. The company reported quarterly sales of $12.7 billion, which beat the analyst consensus estimate of $12.61 billion.

Pfizer sees fiscal year 2020 adjusted EPS $2.82-$2.92 versus the $2.90 estimate and sales $48.5 billion-$50.5 billion versus the $49.52 billion estimate.

Equities Trading UP

Armata Pharmaceuticals, Inc. (NYSE: ARMP) shares shot up 109% to $5.83. Armata Pharmaceuticals and Innoviva reported a $25 million strategic investment to support advancement of Armata's bacteriophage development programs.

Shares of Delphi Technologies PLC (NYSE: DLPH) got a boost, shooting up 63% to $15.92 after the company announced it will be acquired by BorgWarner for $3.3 billion in an all-stock transaction.

Acceleron Pharma Inc. (NASDAQ: XLRN) shares were also up, gaining 52% to $80.20 following a data readout. Acceleron said a Phase 2 study dubbed PULSAR that evaluated its sotatercept in patients with pulmonary arterial hypertension, or PAH, met its primary and key secondary endpoints. The experimental drug showed a statistically significant reduction in pulmonary vascular resistance – the primary endpoint - at week 24 versus placebo. The study also achieved the key secondary endpoint of significant improvements in six-minute walk distance, and other secondary endpoints, including amino-terminal brain natriuretic propeptide, and WHO functional class. It was also found to be generally well tolerated.

Equities Trading DOWN

NanoViricides, Inc. (NYSE: NNVC) shares tumbled 31% to $10.87 after surging 86.98% on Monday.

Shares of TESSCO Technologies Incorporated (NASDAQ: TESS) were down 25% to $9.07 after the company reported downbeat Q3 results.

Allied Healthcare Products, Inc. (NASDAQ: AHPI) was down, falling 23% to $3.3547 after surging 50% on Monday.


In commodity news, oil traded down 0.1% to $53.07, while gold traded down 0.1% to $1,577.20.

Silver traded down 0.4% Tuesday to $17.985, while copper fell 0.3% to $2.5885.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.1%, the Spanish Ibex Index rose 0.5%, while Italy’s FTSE MIB Index rose 1.1% Meanwhile, the German DAX dropped 0.1%, and the French CAC 40 rose 0.2% while UK shares rose 0.3%.


The Federal Open Market Committee will begin its two-day policy meeting today.

U.S. durable goods orders rose 2.4% in December, versus a revised 3.1% decline in the previous month.

The Johnson Redbook Retail Sales Index rose 0.1% during the first three weeks of January versus December.

The S&P Corelogic Case-Shiller home price index climbed 2.6% year-over-year in November, compared to a 2.2% rise in the previous month.

The Treasury is set to auction 52-week bills at 11:30 a.m. ET.

The Treasury will auction 7-year notes at 1:00 p.m. ET.


Related Articles (AHPI + ARMP)

View Comments and Join the Discussion!

Posted-In: Mid-Morning Market UpdateEarnings News Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at